Overview

A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is a study to assess how much of the investigational drug, PF-00298804, is in the blood stream over a period of time (called pharmacokinetic tests or PK) in patients with locally advanced head and neck squamous cell carcinoma who have a (gastrojejunostomy) feeding tube.
Phase:
N/A
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Pfizer